- Business
- Central Pharmaceutical CPC1 Joint Stock Company is a Vietnam-based pharmaceutical distribution, trading, and supply chain enterprise engaged in the wholesale, distribution, import, and export of pharmaceutical products, medical equipment, and healthcare consumables. The company operates through several core business segments, offering a comprehensive portfolio of healthcare solutions that includes finished ethical prescription (ETC) and over-the-counter (OTC) medicines, such as antibiotics, cardiovascular agents, oncological therapies, analgesics, anti-inflammatory medications, gastrointestinal treatments, and respiratory drugs; vaccines, therapeutic sera, and biopharmaceutical formulations; nutritional supplements, vitamins, and functional wellness products; medical devices, diagnostic test reagents, surgical instruments, and hospital consumables; and specialized healthcare logistics services, encompassing temperature-controlled cold-chain storage, bonded warehousing, customs clearance, Good Storage Practice (GSP) and Good Distribution Practice (GDP) compliant freight management, and pharmaceutical regulatory registration consulting. Central Pharmaceutical CPC1 distributes its portfolio to public and private hospital networks, provincial medical centers, research institutions, clinics, and retail pharmacy chains throughout Vietnam.
Originally founded in 1956 and headquartered in Hanoi, Vietnam, Central Pharmaceutical CPC1 Joint Stock Company operates as an integral distribution member within the Vietnam Pharmaceutical Corporation (Vinapharm) network, maintaining extensive logistics centers, branch offices, and regional fulfillment hubs across northern, central, and southern Vietnam. In recent operational developments, the company has expanded and modernized its GSP-certified distribution facilities and automated cold-chain warehousing systems to accommodate rising volumes of temperature-sensitive biologics, vaccines, and specialized specialty medicines. Central Pharmaceutical CPC1 has also forged new strategic distribution partnerships and expanded exclusive agency agreements with multinational pharmaceutical corporations to introduce advanced therapeutic formulations into the domestic hospital tender and commercial pharmacy channels. Furthermore, the company has advanced the digital transformation of its distribution network through the deployment of integrated enterprise resource planning (ERP) systems and B2B electronic ordering platforms to optimize supply chain visibility, inventory management, and fulfillment speed for healthcare providers nationwide.